Literature DB >> 8225589

Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei.

M E Rottenberg1, M Bakhiet, T Olsson, K Kristensson, T Mak, H Wigzell, A Orn.   

Abstract

The role of CD4+ and CD8+ T cells in the surveillance of Trypanosoma cruzi or Trypanosoma brucei brucei was studied in mice which lacked CD4 or CD8 molecules and which were generated by embryonic stem cell technology. Whereas wild-type mice infected with T. cruzi (Tulahuén strain) displayed low levels of parasitemia and no mortality, striking increases in parasite growth and mortality occurred in both CD8- and CD4- mice. On the contrary, CD8- and, to a lesser degree, CD4- mice showed enhanced resistance to T. b. brucei. T-cell-dependent immunoglobulin G-specific responses were produced in CD8- but not CD4- mice. Normal T-cell proliferative responses were measured in both CD4- and CD8- mice. Interleukin-4 production after concanavalin A or anti-CD3 monoclonal antibody stimulation was strikingly enhanced in CD8- but not CD4- spleen cells, whereas gamma interferon production was normal in both CD4- and CD8- spleen cells. Spleen and lymph node cells from CD8- (but not CD4-) mice at 20 days postinfection with T. cruzi had higher levels of interleukin-4 mRNA than the wild-type controls, as shown in a competitive polymerase chain reaction assay. On the other hand, CD4- (but not CD8-) mice at 20 days postinfection with T. cruzi had lower levels of gamma interferon mRNA than the wild-type mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225589      PMCID: PMC281292          DOI: 10.1128/iai.61.12.5129-5133.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Immunity to Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Adv Parasitol       Date:  1980       Impact factor: 3.870

2.  Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells.

Authors:  M Russo; N Starobinas; P Minoprio; A Coutinho; M Hontebeyrie-Joskowicz
Journal:  Ann Inst Pasteur Immunol       Date:  1988 May-Jun

3.  The effect of immuno-depression due to neonatal thymectomy on infections with Trypanosoma cruzi in mice.

Authors:  G A Schmunis; S M Cappa; O C Traversa; J F Janovsky
Journal:  Trans R Soc Trop Med Hyg       Date:  1971       Impact factor: 2.184

4.  Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo.

Authors:  F Plata; F Garcia-Pons; J Wietzerbin
Journal:  Ann Inst Pasteur Immunol       Date:  1987 May-Jun

5.  Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection.

Authors:  F Kierszenbaum; M M Pienkowski
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

Authors:  S G Reed
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

7.  CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule.

Authors:  T Olsson; M Bakhiet; B Höjeberg; A Ljungdahl; C Edlund; G Andersson; H P Ekre; W P Fung-Leung; T Mak; H Wigzell; U Fiszer; K Kristensson
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

8.  Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi.

Authors:  P B Petray; M E Rottenberg; G Bertot; R S Corral; A Diaz; A Orn; S Grinstein
Journal:  Immunol Lett       Date:  1993-01       Impact factor: 3.685

9.  In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Am J Trop Med Hyg       Date:  1985-09       Impact factor: 2.345

10.  Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi.

Authors:  J J Wirth; F Kierszenbaum; G Sonnenfeld; A Zlotnik
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

View more
  46 in total

1.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.

Authors:  Valéria R A Pereira; Virginia M B Lorena; Mineo Nakazawa; Carlos F Luna; Edimilson D Silva; Antonio G P Ferreira; Marco Aurélio Krieger; Samuel Goldenberg; Milena B P Soares; Eridan M Coutinho; Rodrigo Correa-Oliveira; Yara M Gomes
Journal:  Parasitol Res       Date:  2005-04-27       Impact factor: 2.289

3.  Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity.

Authors:  N M Quanquin; C Galaviz; D L Fouts; R A Wrightsman; J E Manning
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.

Authors:  S Frosch; D Küntzlin; B Fleischer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.

Authors:  Carylinda Serna; Joshua A Lara; Silas P Rodrigues; Alexandre F Marques; Igor C Almeida; Rosa A Maldonado
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

6.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

8.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

9.  NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

Authors:  Hisako Kayama; Ritsuko Koga; Koji Atarashi; Megumi Okuyama; Taishi Kimura; Tak W Mak; Satoshi Uematsu; Shizuo Akira; Hiroshi Takayanagi; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

10.  The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.

Authors:  Luiz Roberto Sardinha; Tainá Mosca; Rosa Maria Elias; Rogério Silva do Nascimento; Lígia A Gonçalves; Daniella Zanetti Bucci; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.